Pulmonx Corp Annual Income Tax Expense (Benefit) in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Pulmonx Corp quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2018 to 2023.
  • Pulmonx Corp Income Tax Expense (Benefit) for the quarter ending September 30, 2024 was $192K, a 225% increase year-over-year.
  • Pulmonx Corp Income Tax Expense (Benefit) for the twelve months ending September 30, 2024 was $710K, a 24.8% increase year-over-year.
  • Pulmonx Corp annual Income Tax Expense (Benefit) for 2023 was $571K, a 61.8% increase from 2022.
  • Pulmonx Corp annual Income Tax Expense (Benefit) for 2022 was $353K, a 2.92% increase from 2021.
  • Pulmonx Corp annual Income Tax Expense (Benefit) for 2021 was $343K, a 61% increase from 2020.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Annual (USD)
Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $571K +$218K +61.8% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-27
2022 $353K +$10K +2.92% Jan 1, 2022 Dec 31, 2022 10-K 2024-02-27
2021 $343K +$130K +61% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-01
2020 $213K -$150K -41.3% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-01
2019 $363K +$351K +2925% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 $12K Jan 1, 2018 Dec 31, 2018 10-K 2021-03-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.